The second wave of the pandemic continues to gather pace in Europe and the United States, but the optimistic news about vaccines has trumped these worries in the minds of investors.
Because they see the global boost to economic activity from the vaccine as potentially larger than any loss of fiscal stimulus in 2021, the markets have interpreted the news as a demand shock, raising bond yields and damaging the relative performance of technology stocks versus cyclicals.
For now, this seems to be a rational response. But the persistent failure of governments in the major western democracies to control the pandemic has lessons for the future, particularly for our efforts to tackle climate change.
Public resistance to lockdown measures made early and strict restrictions, accompanied by effective test, trace and isolation policies, politically infeasible in most of Europe and the US all year. But aggressive restrictions and testing regimes have worked well in Asia and the Pacific.
The comparative results are stark. The cumulative Covid-19 death rate per million of the population is nearly 740 in the US, and 760 in the UK, compared with 3 in China and 15 in Japan, according to Johns Hopkins University.
The second wave of the pandemic continues to gather pace in Europe and the United States, but the optimistic news about vaccines has trumped these worries in the minds of investors.
Opposition to enforced lockdowns in the major western countries is to some extent based on a libertarian belief in economic freedom. This is a legitimate political choice that is usually fully justified but has proved costly in current circumstances. Furthermore, public support for strict measures has been eroded by serious operational failings.
Political opinion has also been moulded by the epidemiological and economic characteristics of this pandemic, which are particularly challenging.
Infectious diseases in their initial stages tend to grow at exponential rates. For example, if they double every three days, they will increase 1,000-fold within a month, unless slowed down by social distancing or herd immunity. But human beings struggle to grasp that idea, and instead tend to assume that the number of cases will grow by the same absolute number each day, leading them to underestimate the danger.
This exponential growth fallacy is a well known feature of human behaviour, including in people who are trained to avoid it. The natural time lag between cases, hospitalisations and then deaths further exacerbates the tendency to wait too long before announcing policy restrictions.
Another issue, very familiar to economists, is the pervasive role that externalities have played in the spread of coronavirus. When an infectious person fails to self-isolate, many other people are placed at risk of disease and thus bear the costs of this individual’s decision.
This should present a watertight case for public intervention to enforce social distancing and isolation, especially after positive tests.
That’s because a decision to avoid lockdowns today is likely to lead to exponential growth in cases in the future, resulting in more stringent restrictions, and greater damage to businesses. Considered dynamically, both health and the economy eventually benefit from early and decisive virus control.
Further complicating the response for democracies has been the argument over how to weigh the health benefits of lockdowns and social distancing against the economic costs. Over short periods, the two do conflict, but economist Simon Wren-Lewis has persuasively argued that this is not true in the longer term.
That’s because a decision to avoid lockdowns today is likely to lead to exponential growth in cases in the future, resulting in more stringent restrictions, and greater damage to businesses. Considered dynamically, both health and the economy eventually benefit from early and decisive virus control.
The failure of most western democracies to accept these arguments for early restrictions demonstrates the potency of the behavioural biases involved and their fundamental political belief in free markets.
The arrival of effective vaccines might mean that US president-elect Joe Biden will soon be able to focus beyond the virus. But it is obvious that the problems of market failure that plagued responses to Covid-19 also apply to his other big international focus, climate change.
The effects of climate change also increase exponentially, albeit over a much longer period than a pandemic. Time lags between cause and effect are very lengthy, making interpretation obscure to the public. Externalities are unavoidable, and apply across international borders, making them even harder to address. Human biases leave us systematically underprepared to address serious but remote risks.
The climate problem is therefore even less suited to free market solutions than Covid-19.
America’s promised return to the Paris accord is the first and necessary step on a very long road. No one has thought of a magic bullet for global warming, equivalent to a vaccine against Covid-19. This problem will have to be solved the hard way.
This content is provided for informational purposes and is directed to clients and eligible counterparties as defined in Directive 2011/61/EU (AIFMD) and Directive 2014/65/EU (MiFID II) Annex II Section I or Section II or an investor with an equivalent status as defined by your local jurisdiction. Fulcrum Asset Management LLP (“Fulcrum”) does not produce independent Investment Research and any content disseminated is not prepared in accordance with legal requirements designed to promote the independence of investment research and as such should be deemed as marketing communications. This document is also considered to be a minor non-monetary (‘MNMB’) benefit under Directive 2014/65/EU on Markets in Financial Instruments Directive (‘MiFID II’) which transposed into UK domestic law under the Financial Services and Markets Act 2000 (as amended). Fulcrum defines MNMBs as documentation relating to a financial instrument or an investment service which is generic in nature and may be simultaneously made available to any investment firm wishing to receive it or to the general public. The following information may have been disseminated in conferences, seminars and other training events on the benefits and features of a specific financial instrument or an investment service provided by Fulcrum.
Any views and opinions expressed are for informational and/or similarly educational purposes only and are a reflection of the author’s best judgment, based upon information available at the time obtained from sources believed to be reliable and providing information in good faith, but no responsibility is accepted for any errors or omissions. Charts and graphs provided herein are for illustrative purposes only. The information contained herein is only as current as of the date indicated, and may be superseded by subsequent market events or for other reasons. Some of the statements may be forward-looking statements or statements of future expectations based on the currently available information. Accordingly, such statements are subject to risks and uncertainties. For example, factors such as the development of macroeconomic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. In no case whatsoever will Fulcrum be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages. Reproduction of this material in whole or in part is strictly prohibited without prior written permission of Fulcrum Copyright © Fulcrum Asset Management LLP 2024. All rights reserved.